Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Pasvolsky O"'
Prevalence and Clinical Characteristics of Paraproteinemia Associated with Chronic Myeloid Leukemia.
Autor:
Berger T; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Shacham Abulafia A; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Shimony S; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Pasvolsky O; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Vaxman I; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Miron Y; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel., Feldman S; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel., Leader A; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Raanani P; Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel.; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Publikováno v:
Acta haematologica [Acta Haematol] 2022; Vol. 145 (6), pp. 619-626. Date of Electronic Publication: 2022 Jul 29.
Autor:
Gover-Proaktor A; a Felsenstein Medical Research Center , Beilinson Hospital, Rabin Medical Center , Petah-Tikva , Israel., Granot G; a Felsenstein Medical Research Center , Beilinson Hospital, Rabin Medical Center , Petah-Tikva , Israel., Pasmanik-Chor M; b Bioinformatics Unit, G.S.W. Faculty of Life Sciences , Tel Aviv University , Tel Aviv , Israel., Pasvolsky O; c Institute of Hematology, Davidoff Cancer Center , Beilinson Hospital, Rabin Medical Center , Petah-Tikva , Israel.; d Sackler School of Medicine , Tel Aviv University , Tel Aviv , Israel., Shapira S; a Felsenstein Medical Research Center , Beilinson Hospital, Rabin Medical Center , Petah-Tikva , Israel.; d Sackler School of Medicine , Tel Aviv University , Tel Aviv , Israel., Raz O; a Felsenstein Medical Research Center , Beilinson Hospital, Rabin Medical Center , Petah-Tikva , Israel., Raanani P; c Institute of Hematology, Davidoff Cancer Center , Beilinson Hospital, Rabin Medical Center , Petah-Tikva , Israel.; d Sackler School of Medicine , Tel Aviv University , Tel Aviv , Israel., Leader A; c Institute of Hematology, Davidoff Cancer Center , Beilinson Hospital, Rabin Medical Center , Petah-Tikva , Israel.; d Sackler School of Medicine , Tel Aviv University , Tel Aviv , Israel.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2019 Jan; Vol. 60 (1), pp. 189-199. Date of Electronic Publication: 2018 May 09.